| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |